Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Belani, C. P.
Ramalingam, S.
Schreeder, M.
Steis, R.
Guidice, R.
Marshland, T.
Butler, B.
机构：
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[2] Clearview Canc Inst, Huntsville, AL USA
[3] Atlanta Canc Care, Roswell, GA USA
[4] New Mexico Oncol Hematol Consultants, Albuquerque, NM USA
[5] Integrated Community Oncol Network, Orange Pk, FL USA
[6] Int Oncol Network, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7643
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    [J]. Clinical Drug Investigation, 2001, 21 : 161 - 168
  • [22] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
  • [23] A phase II and pharmacogenomic study of Irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC).
    Pillot, GA
    Hennenfent, K
    Read, W
    Marsh, S
    McLeod, HL
    Gao, F
    Govindan, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [24] Vinorelbine and carboplatin in elderly patients with metastatic non-small cell lung cancer (NSCLC): A multicenter phase II study
    Deppermann, Karl-Matthias
    Ukena, Dieter
    von Pawel, Joachim
    Koschel, Gabriele
    Reck, Martin
    Serke, Monika
    Huber, Rudolf-Maria
    Eberhardt, Wilfried
    Niederle, Norbert
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [25] Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer: Final results
    Yoshimura, N.
    Kudoh, S.
    Kimura, T.
    Mitsuoka, S.
    Yana, T.
    Hirata, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] A phase II study of weekly docetaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Son, C.
    Kim, K.
    Lee, K.
    Yang, D.
    Lee, S.
    Choi, P.
    Cho, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer
    Bennouna, J
    Monnier, A
    Rivière, A
    Milleron, B
    Lemarie, E
    Trillet-Lenoir, V
    Soussan-Lazard, K
    Berille, J
    Douillard, JY
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) : 1107 - 1112
  • [28] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
  • [29] A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer
    Zarogoulidis, K
    Kontakiotis, T
    Hatziapostolou, P
    Fachantidou, E
    Delis, D
    Goutsikas, J
    Constantinidis, TC
    Athanasiadis, A
    Patakas, D
    [J]. LUNG CANCER, 2001, 32 (03) : 281 - 287
  • [30] A phase II study of nedaplatin (CDGP) and docetaxel (TXT) in patients with advanced non-small cell lung cancer (NSCLC)
    Fujino, S.
    Asada, Y.
    Nakano, Y.
    Suzumura, Y.
    Inoue, S.
    Nagao, T.
    Hajiro, T.
    Tezuka, N.
    Sawai, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345